Headquarters
Sweden
Every company in the roster headquartered in Sweden.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
7 of 7 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Calliditas TherapeuticsPrivate | 2 assets: 1 approved, 1 Ph 2 | GKT137831Phase 2 · Primary Biliary Cholangitis | Mar 2027Budesonide (targeted-release) · Approved |
 AlzeCure PharmaPrivate | 1 asset: 1 Ph 1 | ACD856Phase 1 · Alzheimer's DiseasePartial signal | None on record |
 Alzinova ABPrivate | 1 asset: 1 Ph 1 | ALZ-101Phase 1 · Alzheimer's DiseasePartial signal | None on record |
 AnaCardio ABPrivate | 1 asset: 1 Ph 2 | AC01Phase 2 · Heart FailurePartial signal | 30 Jul 2028AC01 · Phase 2 |
 Empros PharmaPrivate | 1 asset: 1 Ph 2 | EMP16Phase 2 · ObesityReliable signal | None on record |
 One-carbon Therapeutics ABPrivate | 1 asset: 1 Ph 2 | TH9619Phase 1/2 · Non-Small Cell Lung Cancer | Dec 2026TH9619 · Phase 1/2 |
 Pila PharmaPILA · Nasdaq First North | 1 asset: 1 Ph 2 | XEN-D0501Phase 2 · Type 2 DiabetesPartial signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).